89 related articles for article (PubMed ID: 9345415)
1. Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis.
Andersen O; Lycke J; Tollesson PO; Svenningsson A; Runmarker B; Linde AS; Aström M; Gjörstrup P; Ekholm S
Mult Scler; 1996 Jul; 1(6):348. PubMed ID: 9345415
[No Abstract] [Full Text] [Related]
2. Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis.
Andersen O; Lycke J; Tollesson PO; Svenningsson A; Runmarker B; Linde AS; Aström M; Gjörstrup P; Ekholm S
Neurology; 1996 Oct; 47(4):895-900. PubMed ID: 8857715
[TBL] [Abstract][Full Text] [Related]
3. Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: a double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation.
Karussis DM; Meiner Z; Lehmann D; Gomori JM; Schwarz A; Linde A; Abramsky O
Neurology; 1996 Aug; 47(2):341-6. PubMed ID: 8757002
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulation with linomide: possible novel therapy for multiple sclerosis.
Abramsky O; Lehmann D; Karussis D
Mult Scler; 1996 Nov; 2(4):206-10. PubMed ID: 9345375
[TBL] [Abstract][Full Text] [Related]
5. Linomide in the treatment of multiple sclerosis: MRI results from prematurely terminated phase-III trials.
Tan IL; Lycklama à Nijeholt GJ; Polman CH; Adèr HJ; Barkhof F
Mult Scler; 2000 Apr; 6(2):99-104. PubMed ID: 10773855
[TBL] [Abstract][Full Text] [Related]
6. Management of relapsing/remitting multiple sclerosis with copolymer 1 (Copaxone).
Johnson KP
Mult Scler; 1996 Jul; 1(6):325-6. PubMed ID: 9345409
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide).
Karussis DM; Lehmann D; Slavin S; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Kalland T; Abramsky O
Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6400-4. PubMed ID: 8341645
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells.
Lehmann D; Karussis D; Mizrachi-Koll R; Linde AS; Abramsky O
Clin Immunol Immunopathol; 1997 Nov; 85(2):202-9. PubMed ID: 9344704
[TBL] [Abstract][Full Text] [Related]
9. [Immune modulation in multiple sclerosis: linomide].
Weilbach EX; Hartung HP
Nervenarzt; 1996 Aug; 67(8):701-5. PubMed ID: 8805117
[No Abstract] [Full Text] [Related]
10. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of autoimmunity by linomide.
Karussis DM; Lehmann D; Slavin S; Kalland T; Vourka-Karussis U; Mizrachi-Koll R; Ovadia H; Abramsky O
Isr J Med Sci; 1995 Jan; 31(1):38-41. PubMed ID: 7836046
[No Abstract] [Full Text] [Related]
12. Lessons from linomide: a failed trial, but not a failure.
Schwid SR; Trotter JL
Neurology; 2000 May; 54(9):1716-7. PubMed ID: 10802772
[No Abstract] [Full Text] [Related]
13. Glatiramer acetate for relapsing multiple sclerosis.
Med Lett Drugs Ther; 1997 Jul; 39(1004):61-2. PubMed ID: 9217693
[No Abstract] [Full Text] [Related]
14. The use of interferon beta in relapsing-remitting multiple sclerosis.
Etheridge LJ; Beverley DW; Ferrie C; McManus E
Arch Dis Child; 2004 Aug; 89(8):789-91. PubMed ID: 15269086
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Togha M; Karvigh SA; Nabavi M; Moghadam NB; Harirchian MH; Sahraian MA; Enzevaei A; Nourian A; Ghanaati H; Firouznia K; Jannati A; Shekiba M
Mult Scler; 2010 Jul; 16(7):848-54. PubMed ID: 20488825
[TBL] [Abstract][Full Text] [Related]
16. Linomide, a new treatment for autoimmune diseases: the potential in type 1 diabetes.
Slavin S; Sidi H; Weiss L; Rosenman E; Kalland T; Gross D
Diabetes Metab Rev; 1993 Dec; 9(4):311-5. PubMed ID: 7924828
[No Abstract] [Full Text] [Related]
17. Guideline for the use of beta-interferons in patients with multiple sclerosis--a South African proposal.
Multiple Sclerosis Advisory Committee of the Neurological Association of South Africa (NASA)
S Afr Med J; 2004 Nov; 94(11):917-21. PubMed ID: 15587456
[TBL] [Abstract][Full Text] [Related]
18. Modulation of experimental systemic lupus erythematosus with linomide.
Zandman-Goddard G; George J; Levy Y; Blank M; Slavin S; Shoenfeld Y
Lupus; 1996 Aug; 5(4):328-33. PubMed ID: 8869907
[TBL] [Abstract][Full Text] [Related]
19. Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial.
Ravnborg M; Sørensen PS; Andersson M; Celius EG; Jongen PJ; Elovaara I; Bartholomé E; Constantinescu CS; Beer K; Garde E; Sperling B
Lancet Neurol; 2010 Jul; 9(7):672-80. PubMed ID: 20542736
[TBL] [Abstract][Full Text] [Related]
20. Copolymer-1.
Comi G; Moiola L
Baillieres Clin Neurol; 1997 Oct; 6(3):495-509. PubMed ID: 10101586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
